Stockreport

Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]

Sensei Biotherapeutics, Inc.  (SNSE) 
PDF - Topline efficacy and biomarker data for both monotherapy and combination arms of dose escalation study now expected in Q2 2024, ahead of previous guidance - - Stron [Read more]